The contract covers the early-stage development and purification of the biological vaccine candidate.
Biovian_signs_a_deal_about_COVID_19_vaccine_development_and_manufacturing
Biovian has signed an agreement with a European biopharmaceutical company for contract development and manufacturing of a COVID-19 vaccine.
The contract covers the early-stage development and purification of the biological vaccine candidate.
Biovian_signs_a_deal_about_COVID_19_vaccine_development_and_manufacturing